Understanding lipidomics associations and the lipoprotein-related caveats in population epidemiology
Mass spectrometry lipidomics is becoming customary to analyze serum/plasma samples in epidemiology. The measurables are molecular constituents of lipoprotein particles, but very little is known about the consequences of adjusting lipidomics data with lipoprotein measures. We studied 2 population cohorts with 5657 and 2036 participants. Liquid chromatography/tandem mass spectrometry lipidomics was applied to analyze 24 molecular lipid classes and nuclear magnetic resonance spectroscopy to quantify 7 lipoprotein lipids plus apolipoprotein A-I and B. The associations of these measures were analyzed via partial Spearman's correlations. The effects of 9 different lipoprotein adjustments on these interrelationships were assessed. Multivariable regression modeling with these adjustments was also performed for the associations between the lipidomics data and body mass index. These novel large-scale lipidomics data and their associations between the lipoprotein measures were coherent in both population cohorts, confirming the compatibility of the analytical approaches. Simulated data were generated to corroborate the mediation effects. The lipoprotein-related lipid transport and metabolism inherently mediate the lipidomics associations, as evident from the striking effects of the lipoprotein adjustments. These effects and their relevance to the interpretations of lipidomics data are presented and discussed in detail for the first time. The combined lipoprotein lipid adjustments appear prone to overadjustment and arbitrary biases.
Authors
- Johannes Kettunen (ORCID: https://orcid.org/0000-0002-3345-491X)
- Ville‐Petteri Mäkinen (ORCID: https://orcid.org/0000-0002-7262-2656)
- Mika A. P. Kähönen (ORCID: https://orcid.org/0000-0002-4510-7341)
- Pauli Ohukainen (ORCID: https://orcid.org/0000-0002-0919-7204)
- Olli T. Raitakari (ORCID: https://orcid.org/0000-0001-9365-3702)
- Siyu Zhao (ORCID: https://orcid.org/0000-0001-9876-7610)
- Marjo‐Riitta Järvelin (ORCID: https://orcid.org/0000-0002-2149-0630)
- Mika Ala‐Korpela (ORCID: https://orcid.org/0000-0001-5905-1206)
- Terho J. Lehtimäki (ORCID: https://orcid.org/0000-0002-2555-4427)
- Jorma Viikari
Institutions
- Tampere University of Applied Sciences (FI)
- University of Turku (FI)
- Tampere University (FI)
- University of Eastern Finland (FI)
- Turku Centre for Computer Science (FI)
- Turku University Hospital (FI)
- Finnish Institute for Health and Welfare (FI)
- Tampere University Hospital (FI)
- Cardiovascular Research Center (BR)
- Tampere University (FI)
- Fimlab (Finland) (FI)
- Health & Life (Taiwan) (TW)
- Imperial College London (GB)
- Brunel University of London (GB)
- Oulu University of Applied Sciences (FI)
- University of Oulu (FI)
Publication Details
- Journal
- American Journal of Epidemiology
- Published
- 2024-11-28
- DOI
- https://doi.org/10.1093/aje/kwae445
- Citations
- 1
- Primary Topic
- Metabolomics and Mass Spectrometry Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.23
Funders
- Foundation for Cardiovascular Research
- Yrjö Jahnssonin Säätiö
- Kela
- Suomen Kulttuurirahasto
- Jane ja Aatos Erkon Säätiö
- Juho Vainion Säätiö
- Signe ja Ane Gyllenbergin Säätiö
- Emil Aaltosen Säätiö
- Sydäntutkimussäätiö
- Tampereen Tuberkuloosisäätiö
- Diabetesliitto
- Paavo Nurmen Säätiö
- Tays
- Syöpäsäätiö
- Directorate for Biological Sciences
- Medical Research Council
- European Regional Development Fund